Forget the unicorn hunt. Outperformance lives in evidence-based asymmetry, mispriced assets, and free options the market ...

Across the recent three months, 11 analysts have shared their insights on ACADIA Pharmaceuticals ACAD, expressing a variety ...

"attachment_1202489" align="aligncenter" width="1456"] A research scientist looking through a microscope in a lab, ...

On Wednesday, BofA Securities analysts increased the price target for Acadia Pharmaceuticals stock (NASDAQ: ACAD) to $23 from $18, while maintaining a Neutral rating. The company, which has shown ...

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United ...

ACADIA Pharmaceuticals Inc. (ACAD) key stats comparison: compare with other stocks by metrics: ... Trading ACAD KRYS SWTX SRPT CYTK ACLX Last Close $21.98 $130.91 $46.75 $38.87 $32.00 $65.14 52 ...

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide ...

NEW YORK, NY – Damian Williams, the United States Attorney for the Southern District of New York, said that a jury has returned a guilty verdict against Amit Dager for insider trading and ...

On Wednesday, BofA Securities analysts increased the price target for Acadia Pharmaceuticals stock (NASDAQ: ACAD) to $23 from $18, while maintaining a Neutral rating. The company, which has shown ...

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...